![]() |
![]() |
Your cart is empty |
||
Books > Medicine > Other branches of medicine > Pathology > Gross pathology
Learn, understand, and master pathophysiology! Corresponding to the chapters in McCance & Huether's Pathophysiology: The Biologic Basis for Disease in Adults and Children, 9th Edition, this study guide offers practical activities and detailed case studies to help you review and remember basic pathophysiology and make the connections between theory and practice. Interactive questions provide you with a working knowledge of disease etiology and disease processes - giving you practice applying what you've learned to clinical practice. Best of all, the answers are in the back of the book so that you can check your understanding as you go! More than 1,200 questions in a wide variety of challenging formats cover all areas of pathophysiology. Practice exams provide immediate feedback by helping you understand the rationale behind each answer. Concise chapter summaries highlight need-to-know information and help you quickly review content. Over 120 illustrations appear in active learning exercises to engage and reinforce understanding for visual learners. Answer key in the back of the study guide allows you to check answers and evaluate your progress. NEW! Thoroughly revised and updated information mirrors content from the 9th edition of the McCance & Huether's Pathophysiology textbook. NEW! Over 40 detailed case scenarios provide real-world examples of how pathophysiology is used in the clinical setting, helping you integrate knowledge, develop clinical judgment, and apply theory to practice.
Exocrine pancreatic tumors of non-ductal origin: Acinar carcinoma, pancreatoblastoma and solid-pseudopapillary neoplasm;? Pancreatic cystic tumors of mucinous type;? Pancreatic cystic lesions of non-mucinous type;? Pancreatic endocrine tumors;? Inflammatory lesions and pseudotumors of the pancreas;? Ductal adenocarcinoma of the pancreas;? PanINs;? Cytology of the Pancreas.
In this issue of Surgical Pathology Clinics, guest editor Lauren L. Ritterhouse brings her considerable expertise to the topic of molecular pathology. Provides in-depth, clinical reviews on molecular pathology, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
This issue of Clinics in Laboratory Medicine, Guest Edited by Zoltan Oltvai, MD, will focus on Conceptual Advances in Pathology. The issue will discuss the convergence of anatomic pathology, clinical pathology and genomics and other sciences, with the technological underpinning of digital pathology. Topics will include: CAD in digital pathology and Modeling protein motion.
The Year Book of Pathology and Laboratory Medicine brings you abstracts of the articles that reported the year's breakthrough developments in pathology and laboratory medicine, carefully selected from more than 500 journals worldwide. Expert commentaries evaluate the clinical importance of each article and discuss its application to your practice. There's no faster or easier way to stay informed
Extranodal Lymphomas is a practical, easy-to-use guide that helps you accurately diagnose even the most challenging cases. Dr. Judith Ferry and leaders in the field present their expertise to fill the need for a highly-illustrated, authoritative reference that keeps you up to date on histologic, immunophenotypic, genetic, and clinical features, along with risk factors and current nomenclature. This comprehensive resource also features access to the fully searchable text and a downloadable image library online at www.expertconsult.com so you'll have convenient access to everything you need for effective diagnostic decision making. Access the fully searchable text online at www.expertconsult.com, along with a downloadable image bank. See specimens as they appear through the microscope with nearly 800 superb, full-color photographs, photomicrographs, and images taken at high power. Apply current criteria for diagnosis with the terminology and criteria of the newest WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues incorporated throughout the text. Easily refer to key information through tables that highlight principle features of lymphomas in different anatomic sites and their differential diagnosis. Effectively diagnose both extranodal and intranodal lymphomas using comprehensive coverage. Quickly find pathologic criteria with chapters organized by anatomic site providing a comprehensive list of extranodal sites, including the central nervous system, the head and neck, heart, lungs, gastrointestinal tract, skin, bone, bone marrow, and more. The definitive textbook on extranodal lymphomas, written by experts in the field of Hematopathology
There are a variety of protocols that are used in infected total joint arthroplasty. This book outlines and details the best possible course of treatment and formulate custom algorithms for every possible case, based on current evidence. It reviews current concepts and "recipes" for the diagnostic and therapeutic procedures (surgical and antibiotic) based on the type of implant, infection and the patient. This book is an essential resource on infected total joint arthroplasty, containing a series of logical and highly detailed instructions that will serve to educate orthopedic surgeons operating in this field on the best approaches, according to detailed and careful research conducted over the last decade.
The seventh in Springer's landmark series of edited volumes on one of the highest-profile subjects in contemporary medicine and scientific endeavour, this volume sets out to cover a staggering range of research into the medical applications of stem cell research. While stem cells are the very stuff of life for multicellular organisms, including us humans, the cancer stem cell is a morbid entity with a robust resistance to therapies including conventional chemotherapy. This authoritative publication explains the regenerative potential of stem cells and their mesenchymal progeny, reviewing clinical applications of the latter in the treatment of cancer, diabetes and neurodegenerative pathologies. It covers the entire range of stem cells with known potential for therapeutic use, from human embryonic to germ cell-derived pluripotent stem cells and hematopoietic stem cells. The chapters also deal with the role of TGF-beta in propagating human embryonic stem cells, and in facilitating their differentiation. Featuring discussions of molecular signaling pathways that modulate mesenchymal stem cell self-renewal and much more, this book is certain to have broad appeal among academicians and physicians alike.
With recent advances of modern medicine more people reach the "elderly age" around the globe and the number of dementia cases are ever increasing. This book is about various aspects of dementia and provides its readers with a wide range of thought-provoking sub-topics in the field of dementia. The ultimate goal of this monograph is to stimulate other physicians' and neuroscientists' interest to carry out more research projects into pathogenesis of this devastating group of diseases.
This issue of Clinics in Laboratory Medicine, Guest Edited by Anthony Odibo and David Krantz, will feature article topics such as: Screening for Chromosomal abnormalities; Cystic fibrosis screening; The role of second-trimester screening, in the post-first trimester screening era; Modifying risk for Aneuploidy with second-trimester ultrasound after a positive serum screen; Cost-effectiveness of Down syndrome screening paradigms; Biochemical and biophysical screening for the risk of Preterm delivery; Pre-implantation genetic diagnosis; Prenatal testing for infectious disease, Thrombophilias, Preeclampsia, Neural Tube Defects; Management of Multiple Pregnancy; Genetic Counseling Issues in Down syndrome Screening; First Trimester Ultrasound Markers; Quality Control of Nuchal Translucency; Clinical Implications of First Trimester Screening; Adverse Pregnancy Outcomes after Positive Screening; First Trimester Combined Screening: Instant Risks Approach.
This timely volume provides an overview to the causes, effects on systems and clinical approaches of metabolic acidosis. Beginning with a basic understanding of the physiology, pathophysiology and development of this disease, subsequent chapters cover the characteristics and context of the processes that can cause it and a thorough presentation of management strategies. Recommended treatments include those carried out by the health care provider as well as the individual patient, such as dietary management. Clinicians and healthcare professionals will find the tools needed to recognize, work up and manage patients with metabolic acidosis in this practical and concise resource.
DNA and RNA fractions can be isolated from a variety of body fluids including whole blood, serum, plasma, urine, saliva and cerebrospinal fluid from both patients and healthy individuals. Such isolates can be exploited in the early detection of clinical disorders, stratification of patients for treatment, treatment monitoring and clinical follow-up.In addition, the use in fetal medicine allows the early detection of fetal sex, Rh factor and aneuploid disorders as well as following both fetal and premature born infant development. This volume is intended as a primer for those who are interested in entering the field of circulating nucleic acids. The areas covered in this volume include: . Background and general biology of circulating nucleic acids . Methodology . Applications of circulating nucleic acids . Quality Assurance . Ethics"
This streamlined "essential" version of the Molecular Pathology
(2009) textbook extracts key information, illustrations and
photographs from the main textbook in the same number and
organization of chapters. It is aimed at teaching students in
courses where the full textbook is not needed, but the concepts
included are desirable (such as graduate students in allied health
programs or undergraduates). It is also aimed at students who are
enrolled in courses that primarily use a traditional pathology
textbook, but need the complementary concepts of molecular
pathology (such as medical students). Further, the textbook will be
valuable for pathology residents and other postdoctoral fellows who
desire to advance their understanding of molecular mechanisms of
disease beyond what they learned in medical/graduate school. "
There is little doubt that information technology is a major force in transforming healthcare systems: physicians need to have considerable patient data at hand, even if diagnosis and treatment are relatively straightforward. But data are only as useful as ICT-information communication technology-systems make them. Inefficient handling of data can quickly lead to chaos, and possibly to fatalities. Strategic ICT Planning in Pathology illuminates these problems, as well as their potential solutions, based on a unique body of research from Australia. Focusing on core strategic factors such as laboratory information systems capability and effectiveness, business-IT alignment, strategic spending, research and education, and end-user involvement, the book explains why pathology labs lag behind other hospital departments. Survey and focus group findings pinpoint the importance of Strategic Information System Planning (SISP), and its relationship to quality service delivery and an improved bottom line [ok?]. Among the topics covered: Approaches to SISP and IS effectiveness measurement. The OpenLabs project and pathology practice. Development of a framework for SISP. Focus groups: the view from the hospital laboratory, the private pathology lab, and the experts. Key findings and their implications for strategy, planning, and business outcomes. Future research directions, including reverse SISP. Strategic ICT Planning in Pathology is a go-to resource for healthcare administrators and researchers in healthcare management, health policy, and health services research interested in troubleshooting systems, conducting surveys on IS, or better understanding how quality ICT works.
The importance of chloride ions in cell physiology has not been
fully recognized until recently, in spite of the fact that chloride
(Cl-), together with bicarbonate, is the most abundant free anion
in animal cells, and performs or determines fundamental biological
functions in all tissues. For many years it was thought that Cl-
was distributed in thermodynamic equilibrium across the plasma
membrane of most cells. Research carried out during the last couple
of decades has led to a dramatic change in this simplistic view. We
now know that most animal cells, neurons included, exhibit a
non-equilibrium distribution of Cl- across their plasma membranes.
Over the last 10 to 15 years, with the growth of molecular biology
and the advent of new optical methods, an enormous amount of
exciting new information has become available on the molecular
structure and function of Cl- channels and carriers. In nerve
cells, Cl- channels and carriers play key functional roles in GABA-
and glycine-mediated synaptic inhibition, neuronal growth and
development, extracellular potassium scavenging,
sensory-transduction, neurotransmitter uptake and cell volume
control. Disruption of Cl- homeostasis in neurons underlies
pathological conditions such as epilepsy, deafness, imbalance,
brain edema and ischemia, pain and neurogenic inflammation. This
book is about how chloride ions are regulated and how they cross
the plasma membrane of neurons. It spans from molecular structure
and function of carriers and channels involved in Cl- transport to
their role in various diseases.
While the basic principles of personalized medicine and pharmacogenomics have been covered by numerous texts, there are none to date that focus on the specific tests themselves that are in current clinical practice and those that are being proposed for implementation in the near future. Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory focuses almost entirely on the specifics of each test that is needed to implement these tests into a clinical laboratory. This volume presents the first compilation of the tests currently in routine clinical use. The chapter authors of this unique and invaluable title comprise a range of renowned authorities and investigators who have conducted the essential clinical trials necessary to justify pharmacogenomic testing today. The book is divided into four parts: Basic Concepts, Specific Pharmacogenomic Targets, Drugs that Cause Delayed Hypersensitivity, and Miscellaneous Drugs. Each author provides a pharmacologic background on the target drug, the need for pharmacogenomic testing, and how results can be translated into clinical decisions. Where appropriate, case studies are given to illustrate typical clinical scenarios. An extensive bibliography is provided so that the reader can refer to the original studies. This well-designed resource will appeal to clinical laboratory directors who are contemplating or assigned the task of establishing a pharmacogenomics laboratory and a wide range of clinicians who must interpret results of testing. Focused and immensely useful, Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory is a timely and outstanding contribution to the literature and will be instrumental in defining this rapidly growing field.
As a result to the recent significant developments, both in the field of cutaneous pathology and clinical dermatology, many cutaneous neural tumors s are now being diagnosed by specialists like dermatopathologists, and treated by dermatologists or dermatologic surgeons. Cutaneous Neural Neoplasms provides an essential aid in diagnosis by discussing the cardinal clinico-pathologic features of cutaneous tumors relevant to these specialists. It covers detailed pathologic features, and their differential diagnosis. Applicable special diagnostic techniques are extensively illustrated. Whenever relevant, key therapeutic recommendations are provided. Unique topics covered include; Discussion of plexiform neural tumors and their imitators, with special relevance to neurofibromatosis Neoplasms with atypical microscopic features, but benign clinical behavior, which are often misdiagnosed as malignant tumors New developments in cutaneous neural tumor diagnosis and recently described neural tumors The authors approach each entity by presenting clinical and/or gross photographs when relevant with discussion of the clinical features, followed by the tabulated list of key pathologic features with corresponding histopathologic illustrations. Therapeutic recommendations are summarized. This book is intended to fill a major gap in the currently available resources for practicing physicians, and will provide them with an appropriate knowledge base to handle these challenging tumors in the most up-to-date fashion.
Many diseases earlier considered to be incurable are now being treated with modern innovations involving fetal tissue transplants and stem cells derived from fetal tissues. Fetal tissues are the richest source of fetal stem cells as well as other varying states of differentiated cells and support or stromal cells. The activity of such stem cells is at their peak provided they are given the correct niche. Stem cells, as we know, are immortal cells with the capacity to regenerate into any kind of differentiated cell as per niche-guidance. As such, fetal tissues have the potential capacity to mend, regenerate and repair damaged cells or tissues in adults, when directly transplanted to the site of injury, or even when transplanted in some other site, because it may have a homing capacity to migrate to the site of the specific injured organ. This is a new area of translational research and needs to be highlighted because of its immense potential. This book will bring together the new work of prominent medical scientists and clinicians who are conducting pioneering research in human fetal tissue transplantation. This will include direct transplant of healthy fetal tissue into mature patients as well as in hosts with genetic diseases. Transplant techniques, donor-host interaction, cell and tissue storage, ethical and legal issues, are some of the many matters which the book will deal with.
After the discovery of milk fat globule-epidermal growth factor-factor 8 (MFG-E8) about two decades ago, a new era of delineating its potential beneficial role in several inflammatory diseases has begun to spout from the bench to translational research. In MFG-E8 and Inflammation, the editor and contributors have gathered a remarkable collection covering novel discoveries on the rapidly growing field of MFG-E8 and Inflammation which includes not only the findings from their individual lobotomies, but also from a host of pioneering researchers of this field. MFG-E8 and Inflammation starts by describing the origin, structure, expression, functions and regulation of MFG-E8, and then continues thoughtfully exploring its potentiality as a marker for apoptotic, stressed and activated cells. The topics cover the cellular and physiological function of MFG-E8, especially its role in efficient phagocytosis of apoptotic cells, intestinal barrier function, blood cell homeostasis and coagulation, and in the maintenance of the intact vascular system. The role of MFG-E8 in macrophages, neutrophils, lymphocytes, dendritic cells, platelets, as well as non-hematopoietic cells is adequately described in the book. The chapters also contain several lucid discussions on the recent discoveries of the roles of MFG-E8 in the autoimmune diseases, sepsis, tissue ischemia-reperfusion, hemorrhage, inflammatory bowel diseases, acute lung injury, asthma, lung fibrosis, stroke, prion diseases and Alzheimer's diseases with the potential focus on elucidating novel mechanistic pathways. MFG-E8 and Inflammation is an indispensable resource for scientists and clinical researchers working on fundamental or applied aspects of MFG-E8 pathobiology. This book explores, dissects and reviews several noteworthy findings and striking future perspectives which not only rewrite the disease pathophysiology, but also update our understanding towards attaining novel therapeutic potentials against various inflammatory diseases.
This second edition updates the burgeoning field of regeneration in
the Central Nervous System (CNS) from molecular, systems, and
disease-based perspective. While the book covers numerous areas in
detail, special emphasis is given to discussions of movement
disorders such as Parkinson s disease, Alzheimer s disease, and
spinal cord injury.
Amyloid-forming proteins are implicated in over 30 human diseases. The proteins involved in each disease have unrelated sequences and dissimilar native structures, but they all undergo conformational alterations to form fibrillar polymers. The fibrillar assemblies accumulate progressively into disease-specific lesions in vivo. Substantial evidence suggests these lesions are the end state of aberrant protein folding whereas the actual disease-causing culprits likely are soluble, non-fibrillar assemblies preceding the aggregates. The non-fibrillar protein assemblies range from small, low-order oligomers to spherical, annular, and protofibrillar species. Oligomeric species are believed to mediate various pathogenic mechanisms that lead to cellular dysfunction, cytotoxicity, and cell loss, eventuating in disease-specific degeneration and systemic morbidity. The particular pathologies thus are determined by the afflicted cell types, organs, systems, and the proteins involved. Evidence suggests that the oligomeric species may share structural features and possibly common mechanisms of action. In many cases, the structure function interrelationships amongst the various protein assemblies described in vitro are still elusive. Deciphering these intricate structure function correlations will help understanding a complex array of pathogenic mechanisms, some of which may be common across different diseases albeit affecting different cell types and systems."
Combined modularized therapies for metastatic cancer are pointing to central problems of communication among 'systems participators'. A communication theory explains 'social engineering', endogenously induced or by implementing non-normative boundary conditions. Evolution-adjusted tumor pathophysiology is borne by an evolution theory, which contrasts narrative evolution histories. The tool of rationalizations constituting the tumor's normativity (inflammation, immune response etc.) represents the non-genomic counterpart of the tumor genome and should be additionally assessed during tumor staging. Evolution-adjusted tumor pathophysiology allows implementing applied systems biology, a novel clinical and pharmaceutical technology for bioengineering tumor response and personalizing tumor therapy. Combined modularized therapy, evolution-adjusted tumor pathophysiology, and 'universal' biomarkers concertedly address genetically based tumor heterogeneity.
This book examines the role that dopamine plays in schizophrenia,
examining its role in not only the symptoms of the disease but also
in its treatment. It also reviews all neurotransmitters that have
been implicated in schizophrenia, exploring the genetic data,
clinical data implicating the transmitter, and the preclinical data
exploring how a transmitter may interact with dopamine and
contribute to the dopaminergic phenotype observed in the illness.
This book will serve as an educational tool for instructors, a
guide for clinicians, and be of interest to researchers. It is a
good reference for researchers specialized in one particular area
and interested in learning about other areas of pathology in
schizophrenia and how they may all feed into each other. The book
concludes with an overall integrative model assembling as many of
these elements as possible.
Developments in telepathology are progressing at a great speed. As a consequence, there is a need for a broad overview of the field. This first ever book on telepathology is presented in such a way that it should make it accessible to anyone, independent of their kno- edge of technology. The text is designed to be used by all prof- sionals, including pathologists, surgeons, nurses and allied health professionals, and computer scientists. In a very short time, driven by technical developments, the field of telepathology has become too extensive to be covered by only a small number of experts. Therefore, this Telepathology book has been written with chapter contributions from a host of renowned international authorities in telepathology (see the Table of Contents and the List of Contributors). This ensures that the subject matter focusing on recent advances in telepathology is truly up to date. Our guiding hope during this task was that as editors of multiple chapters we could still write with a single voice and keep the content coherent and simple. We hope that the clarity of this book makes up for any limitations in its comprehensiveness. |
![]() ![]() You may like...
Advanced Technologies for Managing…
Isaac Ishaaya, Subba Reddy Palli, …
Hardcover
R4,394
Discovery Miles 43 940
Young Children's Language in Context
Sheila Degotardi, Shelley Stagg Peterson, …
Hardcover
R4,454
Discovery Miles 44 540
|